VKTX
Viking Therapeutics, Inc. Earnings
$35.21
Earnings Summary
Net Profits | $-90.79Mn |
Highlights
Net Profits:
Viking Therapeutics, Inc.’s net profit fell -264.02% since last year same period to $-90.79Mn in the Q3 2025. On a quarterly growth basis, Viking Therapeutics, Inc. has generated -38.48% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Viking Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.67 |
EPS Estimate Current Year | -0.67 |
Highlights
EPS Estimate Current Quarter:
Viking Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.67 - a -52.27% fall from last quarter’s estimates.
EPS Estimate Current Year:
Viking Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.67.
Key Ratios
Key ratios of the Viking Therapeutics, Inc. post its Q3 2025 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Viking Therapeutics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Viking Therapeutics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-07-23 | -0.44 | -0.58 | -31.82% |
2025-10-23 | -0.67 | 0 | 100% |
2025-04-24 | -0.31 | -0.41 | -32.26% |
